Clobetasone Butyrate
丁氯倍他松
Report date: 2023/03/16 15:09:34
NME
Base Information
Drug NameClobetasone Butyrate
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date1979/12/31
Country/Territory +[4]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A
Develop Information
Active CompaniesGlaxosmithkline Consumer Healthcare LtdGlaxosmithkline Consumer Healthcare, LpGlaxo Wellcome Operations
Inactive CompaniesGlaxosmithkline Plc
Active Indications
Inactive IndicationsN/A